Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006

Mette Lykke Norgaard, Charlotte Andersson, Peter Riis Hansen, Søren Andersen, Allan Vaag, Tina K Schramm, Fredrik Folke, Lars Køber, Christian Torp-Pedersen, Gunnar H Gislason

    3 Citationer (Scopus)

    Abstract

    Type 2 diabetes is a well-established risk factor for cardiovascular disease and is common among patients with acute myocardial infarction (MI). The extent to which patients with first-time MI develop diabetes requiring glucose-lowering medications (GLM) is largely unknown. The aim of the study was to investigate temporal trends in the initiation of GLM among patients discharged after first-time MI.
    OriginalsprogEngelsk
    TidsskriftCardiovascular Diabetology
    Vol/bind10
    Sider (fra-til)5
    ISSN1475-2840
    DOI
    StatusUdgivet - 1 jan. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006'. Sammen danner de et unikt fingeraftryk.

    Citationsformater